Sodium Nitroprusside Injection
Last Updated: July 10, 2017
Status: Current
Sodium Nitroprusside Injection
Products Affected - Description
-
Nitropress injection, Valeant
25 mg/mL, 2 mL vial, 1 count (NDC 00187-4302-02)
Reason for the Shortage
-
- Valeant has Nitropress available but short-dated.
- Nexus has sodium nitroprusside 25 mg/mL 2 mL vials available.
- Sagent has sodium nitroprusside 25 mg/mL 2 mL vials available.
- Exela launched Nipride RTU 0.5 mg/mL 100 mL vials in March 2017.
Available Products
-
Nipride RTU injection, Exela Pharma Sciences
0.5 mg/mL, 100 mL ready-to-use vial, 1 count (NDC 51754-1006-01)
Sodium Nitroprusside injection, Nexus Pharmaceuticals
25 mg/mL, 2 mL vial, 1 count (NDC 14789-0012-02)
25 mg/mL, 2 mL vial, 1 count (NDC 14789-0012-02)
Sodium Nitroprusside injection, Sagent
25 mg/mL, 2 mL vial, 1 count (NDC 25021-0310-02)
25 mg/mL, 2 mL vial, 1 count (NDC 25021-0310-02)
Estimated Resupply Dates
-
Valeant has Nitropress 25 mg/mL 2 mL vials available with an expiration date of May 2018.
Related Shortages
| Hydralazine Injection | Resolved |
Updated
July 10, June 12, April 11, February 13, 2017; December 16, November 8, June 2, March 11, 2016; December 30, 2015, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
